{"disease":{"id":"psp-progressive-supranuclear-palsy","name":"psp progressive supranuclear palsy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06647641","title":"The CurePSP Genetics Program","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07264283","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":147,"lead_sponsor_name":"Adam Boxer","has_results":false},{"nct_id":"NCT07217665","title":"The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":146,"lead_sponsor_name":"Adam Boxer","has_results":false},{"nct_id":"NCT05956834","title":"A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03330353","title":"Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy","phase":"","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}